Brief: Billiontoone Announces Selection Of Northstar Select® As The New Liquid Biopsy Test
06/01/2026 15:11
Jan 6 (Reuters) - BillionToOne Inc BLLN.O: BILLIONTOONE ANNOUNCES SELECTION OF NORTHSTAR SELECT® AS THE NEW LIQUID BIOPSY TEST FOR LC-SCRUM-TRY CLINICAL STUDY AT NATIONAL CANCER CENTER HOSPITAL EAST BILLIONTOONE- ULTRA-SENSITIVE LIQUID BIOPSY EXPANDING PRECISION MEDICINE ACCESS IN JAPAN WITH TREATMENT-RESISTANT NON-SMALL CELL LUNG CANCER Source text: ID:nPn1d2jGca Further company coverage: BLLN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on BillionToOne
See all newsU.S. STOCKS ON THE MOVE-Braveheart Bio, Paysign, Hertz Global
BillionToOne drops after in-line quarter, maintains annual revenue outlook
U.S. STOCKS ON THE MOVE-Ralph Lauren, Sempra, Parker-Hannifin, Lincoln International
U.S. STOCKS ON THE MOVE- MACOM Technology , Becton Dickinson, Centrus Energy
BillionToOne drops after in-line quarter, maintains annual revenue outlook